Tracker

BPC-157 Tracker: What You Can Record and What Is Unknown

A BPC-157 tracker is a dose and vial log. BPC-157 is not FDA-approved, and the published pharmacokinetic data comes from rats and beagle dogs, not people.[4] PepTrac for iPhone records each BPC-157 dose, vial, and injection site, and it draws its level estimate as a rough range. This page states what is not known before it describes what the app does.

By PepTrac Editorial TeamPublished Updated

What is BPC-157?

BPC-157 is an experimental peptide that appears mainly in animal and laboratory research, and it is not an approved medicine. The U.S. Anti-Doping Agency states that it has not been approved for human clinical use by the FDA or any other global health authority, and that there are no human clinical trials establishing efficacy for any diagnosis or treatment.[3] The FDA has identified no, or only limited, safety-related information for the routes of administration proposed for it, and it points to peptide-related impurities and immunogenicity as concerns for compounded versions.[1] That means a tracker cannot tell you whether BPC-157 is safe or useful, and PepTrac does not try to. What a tracker can do is keep an accurate record of what you entered, when, from which vial, and at which site, so a clinician can review it with you. PepTrac does not sell BPC-157 and does not recommend a dose.

Is BPC-157 FDA-approved or legal to compound?

No, BPC-157 is not FDA-approved for any use, and its compounding status is unsettled as of October 2026. The FDA lists it among bulk drug substances that were nominated for compounding and then withdrawn, and the same page, current as of April 22, 2026, flags immunogenicity risk and peptide-related impurities.[1] According to a summary by the law firm McDermott Will & Schulte, the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with 1 abstention, on July 23, 2026 to recommend BPC-157 and TB-500 for the 503A bulk drugs list. That vote is advisory, and the FDA would still need to complete rulemaking to add them.[2] A recommended listing is not an FDA approval and says nothing about whether a product is safe or effective. This is a moving area, so check the FDA pages again before relying on this paragraph. The sentence reflects what the cited pages said on October 3, 2026.

Is BPC-157 banned in sport?

Yes. The U.S. Anti-Doping Agency states that BPC-157 is prohibited under the S0 Non-Approved Substances category of the World Anti-Doping Agency (WADA) Prohibited List.[3] For an athlete who is subject to anti-doping rules, that status is what counts, and logging a substance in an app does not change it. A tracker is not a compliance tool, and PepTrac does not check any list for you. If you compete under an anti-doping program, confirm the current status of any substance with your governing body or the anti-doping agency in your country before you use it. The USADA page adds that the FDA has not approved BPC-157 and that human trials are lacking, and its S0 category is the one for non-approved substances.[3] The Prohibited List is updated every year, so the category and wording can change between editions, and only the current edition counts.

What is known about the half-life of BPC-157?

Only animal numbers are published in the source PepTrac uses. A 2022 study in Frontiers in Pharmacology gave BPC-157 to rats and beagle dogs by intravenous and intramuscular routes and reported an elimination half-life of under 30 minutes in rats, with a measured value of 15.2 minutes, and about 5.3 minutes in dogs after intravenous dosing.[4] The paper contains no human pharmacokinetic data, and it does not test subcutaneous injection. PepTrac's catalog value for BPC-157 is 0.253 hours, which is the 15.2-minute rat figure, with a time to peak of 0.05 hours. Because those parameters come from animals and not people, treat any BPC-157 curve as a rough illustration of the arithmetic, not as a statement about your body. If you have a better-sourced half-life, the app lets you enter your own value for a compound.

BPC-157: known versus not known, as of October 2026.
QuestionStatusSource
FDA-approved productNone; listed as nominated and withdrawnFDA[1]
Human efficacy trialsNone establishing efficacyU.S. Anti-Doping Agency[3]
Half-lifeUnder 30 minutes in rats; about 5 minutes in dogsXu et al., 2022[4]
Human pharmacokineticsNo human data in the cited studyXu et al., 2022[4]
Compounding statusAdvisory vote on July 23, 2026, per a law-firm summary; rulemaking still neededMcDermott Will & Schulte[2]
SportProhibited under WADA S0U.S. Anti-Doping Agency[3]

What does a BPC-157 level chart actually show?

Very little, and PepTrac says so. With a half-life of 0.253 hours, a logged amount falls away within hours. Take an example entry of 0.25 mg. PepTrac's model reads 0.076 relative units at 30 minutes, with a range of 0.054 to 0.095. At 1 hour it reads 0.019, range 0.010 to 0.030, and at 2 hours it reads 0.001, range 0.000 to 0.003. The amount is an arithmetic example, not a dose recommendation. The curve is a short spike that is gone before most people open the app again. The units are relative, not a blood concentration, and the shaded range only reruns the model with the half-life and peak time changed by 20 percent. It is a sensitivity range, not a statistical confidence interval. For BPC-157 the chart is the least useful part of the app, and the dose, vial, and site records are the part worth keeping.

What is worth recording for BPC-157?

Record the facts that let you or a clinician reconstruct what happened. Useful entries are the date and time, the amount, the vial's lot or batch note, the reconstituted date, the injection site, and anything you plan to report to a clinician. The FDA's concern about peptide-related impurities and the difficulty of characterizing the active ingredient is a practical reason to keep source and vial records.[1] If a problem appears later, a record of which vial and which date it relates to is far more useful than memory. PepTrac logs each dose with its site, keeps a vial for each compound with fill percentage and days left, and shows your most recent sites on a body map. It does not have a dedicated side-effect log or progress photos, so use the notes you keep elsewhere for symptoms, and bring them to a clinician.

How does PepTrac handle BPC-157 vial math?

PepTrac turns the vial size, the water volume, and your dose into a draw volume and syringe units, on a U-100 or U-40 syringe and a 1.0 mL or 0.5 mL barrel. As arithmetic only, a 5 mg vial mixed with 2 mL of water is 2.5 mg per mL, and a 0.25 mg entry is 0.1 mL, which is 10 units on U-100. You can also give the app a target number of units and have it solve for the water volume. These sums are illustrations, not suggested amounts, and you should check every result against the instructions you were given. The app stores the vial for the compound, drains its fill percentage as you log, and shows the days left. It also stores a reconstituted date that you enter, but it does not count down or flag any expiry, so keep your own note of the 28-day discard advice.

For the full method, see the peptide reconstitution calculator and the guide to bacteriostatic water.

Frequently asked questions

Does PepTrac recommend a BPC-157 dose?

No. PepTrac never suggests a dose, schedule, or cycle length for any compound. It stores the amounts you enter and does arithmetic on them. Medical questions belong with a licensed clinician.

Does PepTrac sell BPC-157?

No. PepTrac is record-keeping software for iPhone, published by Blanket LLC. It does not sell, source, or recommend a seller for BPC-157 or any other compound.

Why is my BPC-157 curve almost flat?

The half-life in the source data is very short, 0.253 hours. A logged amount falls to near zero within about two hours, so the curve is a brief spike. That is a property of the data, not a fault in the app.

Can I track BPC-157 together with TB-500?

Yes. Each compound is a separate entry with its own vial, schedule, and curve, and the app never adds curves together. See the peptide stack tracker page for how the weekly grid works.

Where does the BPC-157 half-life number come from?

It comes from a 2022 Frontiers in Pharmacology study in rats and beagle dogs. There is no human data in that paper. You can enter your own half-life for a compound if you have a better source.

Will an athlete test positive for BPC-157?

BPC-157 is prohibited under WADA category S0, according to the U.S. Anti-Doping Agency. This site cannot say whether a test would detect it. Ask your anti-doping organization before using any substance.

Sources

  1. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 3, 2026.
  2. McDermott Will & Schulte. Bulk list bound: PCAC backs majority of peptides in two-day public meeting. Accessed October 3, 2026.
  3. U.S. Anti-Doping Agency. BPC-157: a peptide prohibited by WADA. Accessed October 3, 2026.
  4. PubMed Central, National Library of Medicine. Pharmacokinetics, distribution, metabolism, and excretion of BPC157 in rats and beagle dogs (Xu et al., Frontiers in Pharmacology, 2022). Accessed October 3, 2026.
PepTrac Editorial Team

Written and maintained by the team that builds PepTrac. Every calculator on this site runs the same tested math as the app. Read how we research, cite, and update pages in our editorial policy.

PepTrac app icon

Ready to log your first dose?

PepTrac is free to download for iPhone.

Download on theApp Store